Securities code: 300006 securities abbreviation: Chongqing Lummy Pharmaceutical Co.Ltd(300006) Announcement No.: 2021-088 Chongqing Lummy Pharmaceutical Co.Ltd(300006)
Announcement of resolutions of the second extraordinary general meeting of shareholders in 2021
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Special tips:
1. There is no case of adding, changing or rejecting proposals at this shareholders’ meeting;
2. This general meeting of shareholders does not involve changing the resolution of the previous general meeting of shareholders;
3. The shareholders’ meeting adopts the combination of on-site voting and online voting.
1、 Convening and attendance of the meeting
Chongqing Lummy Pharmaceutical Co.Ltd(300006) (hereinafter referred to as “the company”) issued the notice of the second extraordinary general meeting of shareholders in 2021 in the form of announcement on December 15, 2021. The on-site meeting was held at 15:00 on December 30, 2021 (Thursday) in the conference room on the 13th floor of Chongqing Academy of science and technology, No. 2, Yangliu Road, middle section of Huangshan Avenue, Yubei District, Chongqing by combining on-site voting and online voting. The general meeting of shareholders is presided over by Mr. Peng Weimin, chairman of the company. Some directors, supervisors, senior managers and other relevant persons of the company attended the meeting. The convening, convening and voting procedures of the meeting shall comply with the provisions of laws, administrative regulations, departmental rules, normative documents and the articles of association of the company. A total of 13 shareholders and their authorized representatives attended the meeting, representing 405971704 shares, accounting for 38.4475% of the total share capital of the company. Among them, there are 11 shareholders (hereinafter referred to as “minority shareholders”) except directors, supervisors, senior managers and shareholders who individually or jointly hold more than 5% of the shares of the company, representing 11965640 shares of the company, accounting for 1.1332% of the total share capital of the company. Five shareholders (or entrusted agents) attended the on-site general meeting, representing 394680893 shares, accounting for 37.38% of the total shares of the company; Eight shareholders participated in online voting, representing 11290811 shares, accounting for 1.0693% of the total shares of the company.
2、 Deliberation and voting of proposals
The general meeting of shareholders considered the following proposals by means of on-site open voting and online voting, and formed the following resolutions:
1. To consider and adopt the amendment of the
<公司章程>
Some provisions and proposal on adding party construction work
Voting results: 405879804 shares were approved, accounting for 99.9774% of the shares held by all shareholders attending the meeting; Against 91900 shares, accounting for 0.0226% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting.
Among them, minority shareholders voted 11873740 shares, accounting for 99.2320% of the shares held by minority shareholders attending the meeting; Against 91900 shares, accounting for 0.7680% of the shares held by minority shareholders attending the meeting; Abstained 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting. 2. The proposal on nominating Mr. Liang Jiansheng as a candidate for non independent director of the 5th board of directors of the company was deliberated and adopted
Voting results: 405970604 shares were approved, accounting for 99.9997% of the shares held by all shareholders attending the meeting; Against 1100 shares, accounting for 0.0003% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting.
Among them, the voting of minority shareholders was: 11964540 shares were agreed, accounting for 99.9908% of the shares held by minority shareholders attending the meeting; Against 1100 shares, accounting for 0.0092% of the shares held by minority shareholders attending the meeting; Abstained 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting. 3. The proposal on nominating Ms. Tan Mingyue as a candidate for non employee representative supervisor of the Fifth Board of supervisors of the company was deliberated and adopted
Voting results: 405970604 shares were approved, accounting for 99.9997% of the shares held by all shareholders attending the meeting; Against 1100 shares, accounting for 0.0003% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting.
Among them, the voting of minority shareholders was: 11964540 shares were agreed, accounting for 99.9908% of the shares held by minority shareholders attending the meeting; Against 1100 shares, accounting for 0.0092% of the shares held by minority shareholders attending the meeting; Abstained 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting. 3、 Legal opinions issued by lawyers
Beijing Zhonglun law firm witnessed the general meeting of shareholders through on-site participation and issued the legal opinion. It believes that the convening, convening and voting procedures of the general meeting of shareholders, as well as the qualifications of attendees and conveners, comply with the company law, rules of shareholders’ meeting and other relevant laws and administrative regulations According to the provisions of normative documents and the articles of association, the voting results and resolutions of the general meeting of shareholders are legal and valid.
4、 Documents for future reference
1. Resolution of Chongqing Lummy Pharmaceutical Co.Ltd(300006) 2021 second extraordinary general meeting of shareholders;
2. Legal opinion of Beijing Zhonglun law firm on Chongqing Lummy Pharmaceutical Co.Ltd(300006) the second extraordinary general meeting of shareholders in 2021.
It is hereby announced.
Chongqing Lummy Pharmaceutical Co.Ltd(300006) board of directors December 30, 2021
